首页> 外国专利> Antibody against GD2-O-acetylated ganglioside with pro-apoptotic activity

Antibody against GD2-O-acetylated ganglioside with pro-apoptotic activity

机译:具有促凋亡活性的抗GD2-O-乙酰化神经节苷脂的抗体

摘要

Antibody which binds to the O-acetylated-GD2 ganglioside, includes: a) a light chain including three light chain complementary regions (CDRs) having the following amino acid sequences: CDR1: QSLLKNNGNTFL (SEQ id no 1), CDR2: KVS, CDR3: SQSTHIPYT (SEQ id no 2); and a light chain framework sequence from an immunoglobulin light chain, including the human kappa (κ)CL domain; and b) a heavy chain including three heavy chain complementary regions (CDRs) having the following amino acid sequences: CDR1: EFTFTDYY (SEQ id no 3), CDR2: IRNRANGYTT (SEQ id no 4), CDR3: ARVSNWAFDY (SEQ id no 5), and a heavy chain framework sequence from an immunoglobulin heavy chain, including CH2 and CH3 domains from a human IgG1, and a CH1 domain from a human IgG1, which is mutated to restore pairing between CH1 and light chain that is typical of other human IgG subclasses or substituted by a CH1 domain from such non-IgG1 subclasses as human IgG2, IgG3 or IgG4.
机译:与O-乙酰化的GD2神经节苷脂结合的抗体包括:a)包含三个具有以下氨基酸序列的轻链互补区(CDR)的轻链:CDR1:QSLLKNNGNTFL(SEQ ID no 1),CDR2:KVS,CDR3 :SQSTHIPYT(SEQ ID No 2);以及来自免疫球蛋白轻链的轻链构架序列,包括人κ(κ)CL结构域; b)重链,其包含具有以下氨基酸序列的三个重链互补区(CDR):CDR1:EFTFTDYY(SEQ ID No 3),CDR2:IRNRANGYTT(SEQ ID No 4),CDR3:ARVSNWAFDY(SEQ ID No 5) ),以及来自免疫球蛋白重链的重链框架序列,包括人IgG1的CH2和CH3结构域,以及人IgG1的CH1结构域,将其突变以恢复CH1和其他人典型的轻链之间的配对来自诸如人IgG2,IgG3或IgG4等非IgG1子类的IgG子类或被CH1域取代。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号